The largest database of trusted experimental protocols

Eucamp2 plates

Manufactured by Thermo Fisher Scientific
Sourced in Spain, United States

The EUCAMP2 plates are multi-well culture plates designed for cell culture applications. They feature a standard 96-well format and are made of tissue culture-treated polystyrene. The plates are intended for in vitro use.

Automatically generated - may contain errors

Lab products found in correlation

4 protocols using eucamp2 plates

1

Antimicrobial Resistance Evaluation in Campylobacter

Check if the same lab product or an alternative is used in the 5 most similar protocols
Antimicrobial resistance was evaluated in one isolate per sample. The minimum inhibitory concentration (MIC) was determined using the EUCAMP2 plates (Thermo Scientific, West Palm Beach, FL). The tests were performed according to the manufacturer instructions. The following antibiotics were evaluated: gentamicin, ciprofloxacin, nalidixic acid, tetracycline, streptomycin, and erythromycin. Campylobacter jejuni ATCC 33560 was used as the quality control strain. Epidemiological breakpoint values from the European Committee on Antimicrobial Susceptibility Testing were considered to determine bacterial antibiotic resistance (EUCAST, 2015 ).
+ Open protocol
+ Expand
2

Antimicrobial Susceptibility of Campylobacter

Check if the same lab product or an alternative is used in the 5 most similar protocols
Campylobacter strains were subjected to an antimicrobial susceptibility test (AST) using the broth microdilution method. Sensititre Campylobacter EUCAMP2® plates (Thermo Fisher Scientific®, Madrid, Spain) were used according to the manufacturer’s instructions. Each strain was tested against six different antimicrobials: nalidixic acid (NAL), ciprofloxacin (CIP), erythromycin (ERY), tetracycline (TET), gentamycin (GEN), and streptomycin (STR). The susceptibility or resistance of C. jejuni and C. coli isolates to antimicrobials was determined using the epidemiological cut-off values (ECOFF) established by the European Committee on Antimicrobial Susceptibility Testing (EUCAST, 2023) (Table 1) [35 ]. For other Campylobacter species, the minimum inhibitory concentration (MIC) cut-off values for C. jejuni were applied as they were the most restrictive ones. MDR was defined as resistance to at least three different antimicrobial families [36 (link)].
+ Open protocol
+ Expand
3

Antimicrobial Resistance Profiling of Isolates

Check if the same lab product or an alternative is used in the 5 most similar protocols
The minimum inhibitory concentrations (MIC) for six antimicrobials (ciprofloxacin, erythromycin, gentamicin, nalidixic acid, streptomycin, and tetracycline) were determined by broth microdilution using Thermofisher Sensititre EUCAMP2 plates according to the manufacturer’s protocol. Plates were incubated microaerobically at 41 °C for 24 h. MICs were interpreted using the European Committee on Antimicrobial Susceptibility Testing (EUCAST) epidemiological cut-off (ECOFF) values as wild-type or non-wild-type [27 (link)]. ECOFFs distinguish microorganisms without (wild-type) and with phenotypically detectable acquired resistance mechanisms (non-wild-type) to the antimicrobial in question (https://mic.eucast.org/). Isolates with non-wild-type susceptibilities have been termed microbiologically ‘resistant’, although it is recognised this is not necessarily synonymous with clinical resistance. Multidrug resistance was defined as resistance to three or more antimicrobial classes [27 (link)]. In the panel of antimicrobials tested the quinolone class is represented by ciprofloxacin and nalidixic acid.
+ Open protocol
+ Expand
4

Antimicrobial Resistance Profiling via WGS

Check if the same lab product or an alternative is used in the 5 most similar protocols
For isolates characterized by WGS, antimicrobial resistance was evaluated using minimum inhibitory concentration (MIC) (EUCAMP2 plates; Thermo Scientific, USA). The following antibiotics (and dilution ranges) were evaluated in the panel: gentamicin (GEN; 0.12–16 mg/L), ciprofloxacin (CIP; 0.12–16 mg/L), nalidixic acid (NAL; 1–64 mg/L), tetracycline (TET; 0.5–64 mg/L), streptomycin (STR; 0.25–16 mg/L), and erythromycin (ERY; 1–128 mg/L). MIC classification was interpreted as wild-type (susceptible) or non-wild-type (resistant) using the epidemiological cutoff (ECOFF) defined by European Committee on Antimicrobial Susceptibility (EUCAST) (EFSA et al., 2022 ). The relatedness between AMR genotypes and phenotypes was calculated by dividing the count of resistant isolates based on their genotype by the count of isolates that showed phenotypic resistance (Dahl et al., 2021 (link)).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!